Microbiota–gut–brain axis dysregulation in irritable bowel syndrome: mechanisms, clinical evidence, and therapeutic implications. a narrative review
Internal and Emergency Medicine · 17.11.2026
DOI: 10.1007/s11739-026-04592-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal and Emergency Medicine, online erschienen am 17.11.2026. Verfasst von Simone Saibeni und 4 weiteren Autor:innen. Die Arbeit nennt 134 Literaturangaben.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a heterogeneous disorder of gut–brain interaction in which altered visceral sensitivity, motility, immune activity, epithelial permeability, and microbial metabolism may interact. Microbiota-related associations are frequently reported, but their direction and causal relevance remain uncertain. This narrative review critically examines clinical and mechanistic evidence concerning microbiota–gut–brain communication in IBS, including short-chain fatty acids, bile acids, gaseous metabolites, tryptophan metabolism, environmental exposures, and microbiota-directed interventions. The literature was selected for relevance and interpretability rather than through a systematic evidence-synthesis protocol. Across studies, microbiota-associated differences vary by phenotype, diet, geography, sampling site, and analytical method; no validated IBS-specific microbial signature has emerged. Bile acid metabolism, mucosal immune–neural interactions, and microbial metabolites provide plausible mechanistic links, although much evidence remains associative. Low-FODMAP dietary treatment and rifaximin in appropriately selected patients have clinical trial support, whereas probiotic effects are formulation dependent and fecal microbiota transplantation remains investigational. Microbiome-based precision treatment requires longitudinal phenotyping, standardized sampling, functional multi-omics, and intervention studies demonstrating that microbial or metabolic changes mediate clinical benefit. Microbiome profiling is not yet established as a routine diagnostic test for IBS.
Zitieren
APA
Saibeni, S., Casini, V., Bezzio, C., Manes, G., & Pace, F. (2026). Microbiota–gut–brain axis dysregulation in irritable bowel syndrome: mechanisms, clinical evidence, and therapeutic implications. a narrative review. Internal and Emergency Medicine. https://doi.org/10.1007/s11739-026-04592-8
Vancouver
Saibeni S, Casini V, Bezzio C, Manes G, Pace F. Microbiota–gut–brain axis dysregulation in irritable bowel syndrome: mechanisms, clinical evidence, and therapeutic implications. a narrative review. Internal and Emergency Medicine. 2026. doi:10.1007/s11739-026-04592-8
BibTeX
@article{Saibeni2026,
author = {Saibeni, Simone and Casini, Valentina and Bezzio, Cristina and Manes, Gianpiero and Pace, Fabio},
title = {Microbiota–gut–brain axis dysregulation in irritable bowel syndrome: mechanisms, clinical evidence, and therapeutic implications. a narrative review},
journal = {Internal and Emergency Medicine},
year = {2026},
doi = {10.1007/s11739-026-04592-8}
}
EUVIMED